MSC Therapy for Graft-versus-Host Disease: What 15 RCTs and a Biomarker-Guided Trial Tell Us

A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.

Read more...

Pediatric Applications of Stem Cell Therapy

Stem cell therapy holds immense promise for treating rare diseases in children, offering hope for conditions that are often difficult to manage with conventional treatments. Mesenchymal stem cells (MSCs) are particularly valuable in pediatric applications due to their safety and regenerative potential, addressing disorders like cerebral palsy, muscular dystrophy, and...

Read more...

Revolutionizing Cancer Treatment with CIK Cells

When it comes to modern medicine, advancements in cancer treatment and immune system rejuvenation are among the most exciting fields of study. One such breakthrough involves Cytokine-Induced Killer (CIK) cells. These specialized immune cells are showing promise in the fight against cancer and even offer potential for rejuvenating the immune...

Read more...

Hematopoietic Stem Cell Transplantation: An Advanced Treatment Option for Blood-Related Diseases

Hematopoietic stem cell transplantation (HSCT) is a medical procedure that involves the transplantation of stem cells that are capable of forming blood cells. This advanced treatment option is used to treat various blood-related diseases such as leukemia, lymphoma, and multiple myeloma. HSCT has been found to be highly effective in...

Read more...

Sleeper cells: Newly discovered stem cell resting phase could put brain tumors to sleep

Biomedical engineering researchers developed a new cell classifier tool that takes a higher-resolution look at the life cycle of neuroepithelial stem cells, which led to the discovery and exploration of a new resting phase called Neural G0. This knowledge could help scientists to better understand glioma brain tumors and develop...

Read more...

Identification of Liver Cancer Stem Cell Stemness Markers Using a Comparative Analysis of Public Data Sets

National Institutes of Health and other agencies are funding high-throughput genomics and transcriptomics (‘omics) experiments that deposit digital samples of data into the public domain at a rapidly increasing scale.1,2 The importance of these digital samples of data is further illustrated by the growing number of linked peer-reviewed publications...

Read more...
Top